BR0209864A - Composição de galato de epigalocatequina - Google Patents

Composição de galato de epigalocatequina

Info

Publication number
BR0209864A
BR0209864A BR0209864-4A BR0209864A BR0209864A BR 0209864 A BR0209864 A BR 0209864A BR 0209864 A BR0209864 A BR 0209864A BR 0209864 A BR0209864 A BR 0209864A
Authority
BR
Brazil
Prior art keywords
epigallocatechin gallate
gallate composition
composition
egcg
granulate
Prior art date
Application number
BR0209864-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Chyi-Cheng Chen
Bruno Leuenberger
Original Assignee
Roche Vitamins Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8178165&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0209864(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Vitamins Ag filed Critical Roche Vitamins Ag
Publication of BR0209864A publication Critical patent/BR0209864A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fertilizers (AREA)
BR0209864-4A 2001-07-30 2002-07-22 Composição de galato de epigalocatequina BR0209864A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01118246 2001-07-30
PCT/EP2002/008127 WO2003011339A1 (en) 2001-07-30 2002-07-22 Composition for epigallocatechin gallate

Publications (1)

Publication Number Publication Date
BR0209864A true BR0209864A (pt) 2004-06-08

Family

ID=8178165

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209864-4A BR0209864A (pt) 2001-07-30 2002-07-22 Composição de galato de epigalocatequina

Country Status (13)

Country Link
US (1) US20040198673A1 (enExample)
EP (1) EP1411986B1 (enExample)
JP (1) JP2005501833A (enExample)
KR (1) KR100611855B1 (enExample)
CN (2) CN101028253A (enExample)
AT (1) ATE388723T1 (enExample)
AU (1) AU2002327893B8 (enExample)
BR (1) BR0209864A (enExample)
CA (1) CA2450772C (enExample)
DE (1) DE60225560T2 (enExample)
ES (1) ES2301670T3 (enExample)
MX (1) MXPA04000618A (enExample)
WO (1) WO2003011339A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006087164A1 (en) 2005-02-15 2006-08-24 Dsm Ip Assets B.V. Compositions containing polysaccharides
CN100446762C (zh) * 2005-09-05 2008-12-31 中山大学 （-）-表没食子儿茶素没食子酸酯固体分散体及其制备方法与应用
KR20100075960A (ko) * 2007-10-29 2010-07-05 디에스엠 아이피 어셋츠 비.브이. 레스베라트롤 및 펙틴을 함유하는 조성물
CA2885388C (en) 2012-10-04 2018-01-02 Abbott Laboratories Methods for enhancing the effect of egcg on mitigating skeletal muscle loss
WO2015136551A2 (en) * 2014-03-12 2015-09-17 Tata Chemicals Limited A molecular complex of epigallocatechin-3-gallate and a process for production thereof
CN104719910B (zh) * 2015-04-19 2017-07-28 福州乾正药业有限公司 具有热稳定性的egcg固体分散体组合物及其制备方法和应用
CN113384781B (zh) * 2020-03-11 2024-03-29 李彤 一种egcg雾化系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666484A (en) * 1969-11-12 1972-05-30 Lipton Inc Thomas J Process for making a spray-dried instant tea of desired bulk density
US4268533A (en) * 1979-11-21 1981-05-19 General Foods Corporation Quick-set low methoxyl pectin composition
JPS5759803A (en) * 1980-09-30 1982-04-10 Takeda Chem Ind Ltd Granule of l-sodium ascorbate, its preparation, and tablet comprising it
AU587863B2 (en) * 1985-10-07 1989-08-31 Basf Aktiengesellschaft Vitamin-containing granules and production thereof
US4800096A (en) * 1987-05-29 1989-01-24 General Foods Corporation Pectin gelling composition
JP2812682B2 (ja) * 1988-05-24 1998-10-22 株式会社伊藤園 コレステロール排泄促進剤及びコレステロール排泄促進飲食物
DE3903217A1 (de) * 1989-02-03 1990-08-09 Boehringer Ingelheim Vetmed Verfahren zur herstellung fester pharmazeutischer zubereitungen
JPH03141220A (ja) * 1989-10-26 1991-06-17 Tsumura & Co 抗レトロウイルス剤
US4935256A (en) * 1989-10-31 1990-06-19 Procter & Gamble Company Process for making green tea solids
PT96229B (pt) * 1989-12-22 1998-06-30 Syntex Pharma Int Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
JPH0595988A (ja) * 1990-10-22 1993-04-20 Kanebo Ltd 漢方エキス造粒物および漢方エキス含有固形製剤の製造方法
JPH04253918A (ja) * 1991-02-05 1992-09-09 Mitsui Norin Kk 血糖上昇抑制剤
JP3469258B2 (ja) * 1992-10-09 2003-11-25 太陽化学株式会社 腎機能改善用剤
US5486507A (en) * 1994-01-14 1996-01-23 Fuisz Technologies Ltd. Porous particle aggregate and method therefor
JPH07223941A (ja) * 1994-02-14 1995-08-22 Nippon Ham Kk 抗補体作用物質
JP4127864B2 (ja) * 1994-09-29 2008-07-30 太陽化学株式会社 グラム陰性菌増殖抑制剤
JPH08253423A (ja) * 1995-01-19 1996-10-01 Tokushu Meneki Kenkyusho:Kk ラクトフェリン含有食品・医薬品顆粒およびその製造 方法
AU689036B2 (en) * 1995-05-10 1998-03-19 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
US5997937A (en) * 1996-05-06 1999-12-07 Kraft Foods, Inc. Quick-setting gel mix
DE19627344A1 (de) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutisch wirksame bzw. gesundheitsfördernde Zubereitung aus definierten Polyphenolverbindungen
JP4098376B2 (ja) * 1996-09-05 2008-06-11 ビーエーエスエフ ソシエタス・ヨーロピア 錠剤特性の優れた水溶性ビタミン組成物およびその製造法
WO1998029098A1 (en) * 1996-12-31 1998-07-09 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
JPH10279486A (ja) * 1997-04-02 1998-10-20 Taiyo Kagaku Co Ltd 免疫賦活組成物
JPH11116475A (ja) * 1997-10-07 1999-04-27 Snow Brand Milk Prod Co Ltd 炎症性腸疾患予防及び／又は治療剤
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules
US6410052B1 (en) * 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
AU4043900A (en) * 1999-03-30 2000-10-16 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
JP4082823B2 (ja) * 1999-05-06 2008-04-30 日本メナード化粧品株式会社 光毒性抑制剤
JP4731777B2 (ja) * 1999-10-12 2011-07-27 マルホ株式会社 経口医薬組成物
US20040202714A1 (en) * 1999-10-12 2004-10-14 Daiichi Suntory Pharma Co., Ltd. Oral pharmaceutical composition
FI20000004A0 (fi) * 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke...
JP3694733B2 (ja) * 2000-06-29 2005-09-14 独立行政法人農業・生物系特定産業技術研究機構 抗アレルギー剤
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom

Also Published As

Publication number Publication date
DE60225560D1 (de) 2008-04-24
CA2450772A1 (en) 2003-02-13
MXPA04000618A (es) 2005-06-17
EP1411986A1 (en) 2004-04-28
AU2002327893A1 (en) 2003-02-17
KR100611855B1 (ko) 2006-08-11
ES2301670T3 (es) 2008-07-01
DE60225560T2 (de) 2009-04-02
AU2002327893B2 (en) 2006-12-21
WO2003011339A1 (en) 2003-02-13
CA2450772C (en) 2008-09-30
CN101028253A (zh) 2007-09-05
EP1411986B1 (en) 2008-03-12
JP2005501833A (ja) 2005-01-20
AU2002327893B8 (en) 2007-01-18
US20040198673A1 (en) 2004-10-07
ATE388723T1 (de) 2008-03-15
CN1325049C (zh) 2007-07-11
CN1509186A (zh) 2004-06-30
KR20040032872A (ko) 2004-04-17

Similar Documents

Publication Publication Date Title
UY27346A1 (es) Composiciones farmaccuticas que contienen conjuntos de polemero y frrmaco.
DK1644348T3 (da) Epoxy-afsluttede polythioethere, Epoxy-afsluttede polythioethere
DE60233234D1 (en) Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme
BR0108920A (pt) Sistema de comunicação via rádio e internet
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
MXPA04001785A (es) Benzofurano y derivados de dihidrobenzofurano utiles como agonistas de beta-3 adrenoreceptores.
DE50012008D1 (de) Zementzusammensetzungen, enthaltend redispergierbare Polymerisatpulver
MXPA03004549A (es) Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
CL2004001085A1 (es) Compuestos derivados de quinolil propil piperidina, procedimiento de preparacion; compuesto intermediario; composicion farmaceutica, utiles como agentes microbianos.
PL375874A1 (pl) Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu
BR0305767A (pt) Métodos e composições para a preparação de derivados de ácido 4-substituìdo 3-hidroxibutìrico
AR035293A1 (es) Composicion oftalmica.
DK1536783T3 (da) Faste formuleringer, der omfatter en indolinonforbindelse
AU2003293592A8 (en) Novel nutraceutical compositions comprising epigallocatechin gallate
MX2008002492A (es) Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
BR0209864A (pt) Composição de galato de epigalocatequina
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
TWI256304B (en) Pharmaceutical compositions based on azetidine derivatives
AU3163100A (en) Benzofuran-2-one
AU2002357184A1 (en) SUBSTITUTED 6H-DIBENZO(c,h)CHROMENES AS ESTROGENIC AGENTS
TW200621160A (en) Anti-termite agent
DE502004003470D1 (de) Wasserlösliche, fluoreszierende perylentetracarbonsäure bisimide
PT1204659E (pt) Benzofuranos serotoninergicos
NO20063293L (no) Farmasoytiske forbindelser

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: DSM IP ASSETS B.V. (NL)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.